Emerging Trends in Atrial Fibrillation Treatment: Less Dependence on Blood Thinners and Procedures
The CLOSURE-AF trial found that percutaneous left atrial appendage closure (LAAC) was inferior to best medical therapy in preventing stroke and related outcomes in high-risk atrial fibrillation patients, with procedural risks and signals of inefficacy raising concerns about its use.